secwatch.observer — SEC 8-K summary
======================================

Issuer:     TELA Bio, Inc. (TELA)
CIK:        0001561921
Form:       8-K
Filed at:   2025-05-30T23:59:59+00:00
Accession:  0001104659-25-054867
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

TELA Bio stockholders approve 3.5M share increase to equity plan and officer liability limitation
--------------------------------------------------------------------------------

- Class III directors Blizard, Burgess, O'Brien elected; Burgess received only 9.75M votes for vs 19.54M withheld.
- Equity plan amendment approved (20.03M for, 9.25M against); adds 3.5M shares, removes evergreen provision.
- Charter amendment to limit officer liability passed (23.84M for, 5.41M against).
- Non-binding say-on-pay approved with 23.03M for; annual frequency selected (26.94M for 1-year).
- KPMG LLP ratified as auditor for 2025 with 31.84M votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1561921/000110465925054867/0001104659-25-054867-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1561921/000110465925054867/tm2516546d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-054867

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer